The present work reveals a novel regulatory pathway of LINC00152/miR-139-5p/NOTCH1 in CRC, suggesting that LINC00152 is a new prognostic factor and potential therapeutic target in CRC. Here, CYTOR is linked to colorectal carcinoma.